AVTE — Aerovate Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Aerovate Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3.51	4.57	167	129	122
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3.51	4.68	174	131	124
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0.039	0.728	1.25	0.902
Other Long Term Assets
Total Assets	3.51	4.71	175	135	127
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.657	1.77	2.55	7.78	17.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.16	1.77	2.94	8.56	18
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.357	2.94	172	127	109
Total Liabilities & Shareholders' Equity	3.51	4.71	175	135	127
Total Common Shares Outstanding